Infant Formula Transition Plan for Exercise of Enforcement Discretion: Guidance for Industry
FDA-2022-D-0814-0003Other
Comments
1
Last activity Jun 14, 2026
Deadline
Closed on Nov 8, 2022
Closed Nov 8, 2022
Net supportiSupport minus oppose · campaigns included
+100%
+100% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Infant Formula Transition Plan for Exercise of Enforcement Discretion: Guidance for Industry
- Posted
- Oct 6, 2022
- Comment period
- Oct 6, 2022 – Nov 8, 2022
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+100%
Net support
Support1
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Oct 6, 2022Deadline Nov 8, 2022
Jun 8
Support1Oppose0Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.